DROPSORDRY(TM)
Natural health product licensed in Canada
- Other names
- UrgeFreeTM
- Licence holder
- CK Ingredients Inc.
- NPN or DIN-HM
- 80087522
- Status
- Active licence
- Licence date
- 1 August 2018
- Revision date
- 22 August 2018
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cucurbita pepo Source : Cucurbita pepo - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 4,457.5 mg Potency : 3.46 % Polyphenols | 445.75 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline, Dioxyde de titane, Acide stéarique, Hydroxypropyl méthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
DROPSORDRY(TM) helps to decrease nighttime urinary episodes in women due to overactive bladder. DROPSORDRY(TM) helps to reduce urge to urinate and frequency of urination in women due to overactive bladder. DROPSORDRY(TM) helps to relieve symptoms associated with overactive bladder such as nocturia, frequent urination and urgency in women. May reduce severe and frequent menopausal symptoms (such as hot flashes and/or night sweats). DROPSORDRY(TM) helps to reduce frequency of urination at night in men. In general, DROPSORDRY(TM) helps to relief urinary disturbance/symptoms associated with overactive bladder in women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRT). including thyroid hormone replacement therapy. Consult a health care practitioner prior to use due to possible estrogenic effect. Discontinue use and consult a health care practitioner if you experience breast pain, breast swelling, discomfort and/or tenderness or if you experience a recurrence of menstruation and/or uterine spotting. Consult a health care practitioner prior to use if you are attempting to conceive. Consult a health care practitioner prior to exclude any serious conditions. Discontinue use and consult a health care practitioner if you experience erectile dysfunction and/or changes in mood, libido or hair growth.
Source
Official Health Canada record, licence 80087522
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging